PEN Penumbra, Inc. SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Best Medical Devices Stocks 2026 →

Penumbra (PEN) Stock: Buy, Sell, or Hold?

$321.72
+0.26 (+0.08%) ▲
5d: -0.23% 30d: +0.53% 90d: -1.54%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (85%)
Quality Score
61/100
Position
FAIR
30-Day Fair Range
$318.58 – $323.41
Position: FAIR
Forward P/E & Valuation
52.2x FAIR
vs 55.1x historical avg
Wall Street Target
$362.54
+12.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$318.32 / $324.76
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: PEN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

Get Alerted When PEN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$299.97
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$186.26
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PEN is currently trading at $321.72, which is considered fair relative to its 30-day fair value range of $318.58 to $323.41. The stock's valuation (Forward PE: 52.2) is in line with its historical norms (55.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, PEN is in a uptrend. The price is currently testing key support at $318.32. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: PEN scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $362.54 (+12.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $318.58 - $323.41
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 84.6%

Trading Range & Key Levels

30-Day Trading Range $318.58 - $323.41
Current vs Trading Range FAIR
Expected Move (7 Days) ±$6.36 (2.0%)
Support Level $318.32
Resistance Level $324.76
Current Trend Uptrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (73/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($362.54)
  • BULLISH: Bottoming setup score 73/100 — corrected, stabilizing, and turning up

Fundamental Context

Forward P/E (Next Year Est.) 52.21
Wall Street Target $362.54 (+12.7%)
Revenue Growth (YoY) 15.6%
Earnings Growth (YoY) -8.5%
Profit Margin 10.1%
Valuation Discount vs History -1.8% cheaper
PE vs Historical 52.2 vs 55.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.8% (market-implied from PE analysis)
1-Year Target $315.93 (-2%)
2-Year Target $310.24 (-4%)
3-Year Target $304.66 (-5%)
3-Yr Target (if PE normalizes) (PE: 52→55) $321.49 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 52.2, Growth: 25.6%) $638.17 (+98%)
Base: (SPY PE: 19.9, Growth: 25.6%) $242.73 (-25%)
Bear: (PE: 16.9, Growth: 25.6%) $206.32 (-36%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (56x PE), but valuation improves significantly next year (52x PE) as earnings recover.
Forward PE: 55.56 | Forward EPS (Implied): $5.79
Bull Case $388.16 (+21%)
Analyst growth 15.0%, PE expands to 58.3
Base Case $321.46 (0%)
Market implied 0.0%, PE stable at 55.6
Bear Case $245.92 (-24%)
Severe decline -15.0%, PE contracts to 50.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 52.2 to 55.1
Stabilization Target: $339.50 (+5.5%)
PE Expansion Potential: +5.5%
Share PEN Analysis

Share this live PEN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (PEN)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 15, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits user expresses optimism about Penumbra Inc.'s ($PEN) earnings potential, buyback shares, and acquisitions despite market skepticism.
Key Retail Themes: Buyback shares and acquisitions Market skepticism
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:25 PM ET
Data refreshes hourly during market hours. Next update: 6:25 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PEN.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
BUY
31 analysts
$50 53 HOLD
SYK
Stryker Corporation
STRONG BUY
30 analysts
$340 38 SELL
MDT
Medtronic PLC
BUY
30 analysts
$105 39 SELL
PODD
Insulet Corporation
BUY
26 analysts
$178 45 HOLD
IRTC
iRhythm Technologies Inc
STRONG BUY
16 analysts
$166 46 HOLD

Advanced PEN Option Strategies

Professional options setups generated by AI based on today's PEN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive PEN Research Pages
PEN Technical Chart PEN Price Prediction PEN Intrinsic Value DCF PEN Earnings Date PEN Investment Advisor PEN Fair Price Analyzer PEN Options Chain PEN Options Advisor PEN Options Analysis PEN Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals